CME Group Inc. (CME)
Here Are 4 Fantastic Dividends Yielding 6% To Avoid The 'Cash Trap'
Americans are earning record-high investment income due to elevated interest rates, boosting money market funds and Treasury bills. As rates drop, investors will need to shift to higher-risk assets for sustained income, posing challenges for maintaining financial stability. To navigate this shift, I suggest focusing on stocks with strong dividends and growth potential, offering a balance of income and risk.
CME Group Analyst Turns Bearish On 'Credible' Competitor's Market Entry: FMX Exchange's Partners Are 'Frustrated'
Shares of CME Group Inc CME tanked in early trading on Friday, on the heels of alleged insider selling.
3 Crypto Stocks to Watch as Ethereum Rises on Regulatory Win
HIVE Digital (HIVE), CME Group (CME) and BlackRock (BLK) are three Ethereum-exposed stocks that should be tracked as the Bitcoin rival wins a compliance battle with the SEC.
Supply constraints, demand growth are bullish for both sides of the gold:silver ratio – CME Group's Norland
Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
Here's Why Hold Strategy is Apt for CME Group (CME) Stock
CME Group (CME) stands to benefit from its global presence, compelling product portfolio and focus on over-the-counter clearing services and optimistic growth projections.
The 3 Best Crypto Stocks to Buy in June 2024
Today we introduce three of the best crypto stocks to buy in the second half of 2024. Wall Street has noted that cryptocurrency shares are capitalizing on the growing acceptance of digital currencies and attracting investors seeking diversification and growth.
Looking For (Special) Dividends? CME Group Remains One Of My Best Ideas In Finance
CME Group, the largest futures exchange in the world, plans to launch bitcoin trading to capitalize on the increasing demand for crypto-related investments. The company's wide-moat business model, with a portfolio of futures, options, and OTC products, gives it a competitive advantage in the finance sector. CME Group's exclusive licenses and limited competition risk in major product categories make it a strong player in the futures and options market.
Beacon Pointe Advisors LLC Acquires 588 Shares of CME Group Inc. (NASDAQ:CME)
Beacon Pointe Advisors LLC increased its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 6.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,200 shares of the financial services provider’s stock after acquiring an additional 588 shares during the period. Beacon Pointe Advisors LLC’s holdings in CME Group were worth $1,938,000 at the end of the most recent reporting period. Other hedge funds and other institutional investors have also bought and sold shares of the company. Northwest Financial Advisors purchased a new position in CME Group in the 4th quarter worth approximately $28,000. Harbor Investment Advisory LLC boosted its position in shares of CME Group by 966.7% during the fourth quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock valued at $34,000 after buying an additional 145 shares during the last quarter. BKM Wealth Management LLC bought a new stake in CME Group in the 4th quarter worth about $38,000. Atticus Wealth Management LLC purchased a new position in CME Group in the 3rd quarter worth about $40,000. Finally, GoalVest Advisory LLC lifted its stake in CME Group by 1,233.3% during the 4th quarter. GoalVest Advisory LLC now owns 200 shares of the financial services provider’s stock valued at $42,000 after acquiring an additional 185 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock. CME Group Price Performance CME stock opened at $213.14 on Monday. CME Group Inc. has a 52 week low of $175.73 and a 52 week high of $223.80. The firm has a market capitalization of $76.75 billion, a P/E ratio of 24.25, a price-to-earnings-growth ratio of 5.64 and a beta of 0.48. The company has a fifty day simple moving average of $212.46 and a two-hundred day simple moving average of $211.32. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.44 by $0.06. The business had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.48 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The company’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same period last year, the company earned $2.42 EPS. Analysts anticipate that CME Group Inc. will post 9.72 earnings per share for the current fiscal year. CME Group Dividend Announcement The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Friday, June 7th will be given a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.16%. The ex-dividend date is Friday, June 7th. CME Group’s dividend payout ratio (DPR) is currently 52.33%. Insiders Place Their Bets In other news, Director Terry L. Savage sold 2,500 shares of the company’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $210.65, for a total value of $526,625.00. Following the transaction, the director now directly owns 17,441 shares in the company, valued at $3,673,946.65. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, Director Terry L. Savage sold 2,500 shares of the firm’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $210.65, for a total transaction of $526,625.00. Following the transaction, the director now owns 17,441 shares in the company, valued at $3,673,946.65. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Terrence A. Duffy sold 40,000 shares of the stock in a transaction dated Monday, April 29th. The stock was sold at an average price of $210.91, for a total transaction of $8,436,400.00. Following the transaction, the chief executive officer now owns 67,455 shares in the company, valued at $14,226,934.05. The disclosure for this sale can be found here. Insiders sold a total of 49,640 shares of company stock valued at $10,464,924 over the last 90 days. Insiders own 0.30% of the company’s stock. Analyst Upgrades and Downgrades A number of research analysts recently weighed in on CME shares. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $210.00 price objective (down previously from $235.00) on shares of CME Group in a research report on Friday, April 5th. Rosenblatt Securities reiterated a “sell” rating and set a $187.00 target price (up from $185.00) on shares of CME Group in a research report on Thursday, April 25th. Barclays increased their price objective on shares of CME Group from $226.00 to $228.00 and gave the stock an “equal weight” rating in a research note on Thursday, April 25th. Argus lifted their target price on shares of CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. Finally, JPMorgan Chase & Co. increased their price target on CME Group from $198.00 to $206.00 and gave the stock a “neutral” rating in a research note on Thursday, April 25th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $217.80. Check Out Our Latest Stock Report on CME Group CME Group Company Profile (Free Report) CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. Read More Five stocks we like better than CME Group How to Calculate Options Profits Canada Goose Flies Higher Driven By DTC Growth How to Use Stock Screeners to Find Stocks CVS Health Stock Has a Silver Lining Called Value 3 Must-Buy Warren Buffett Stocks for Volatile Times Magnificent 7 Still Magnificent as the Halfway Mark Approaches?
Here's Why You Should Stay Invested in CME Group (CME) Stock
CME Group's (CME) global presence, compelling product portfolio and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
